Allcyte

Allcyte is a biotech start-up company focused on functional drug testing in primary human material. With our Pharmacoscopy high-content imaging platform and AI-supported image analysis pipelines, our mission is to bring the next generation of personalized medicine to cancer patients and treating physicians, and support pharmaceutical companies to focus their drug development efforts on the right molecules in the right indications.

We enable research through the image-based quantification of single-cell phenotypes - all performed directly in primary patient material with minimal amounts of manipulation and requiring minimal amounts of sample. We integrate these data using cutting edge methods of statistics and machine learning to generate actionable insights for our customers. Our mission is to help you make the best possible biomedical decisions.

Allcyte headquartered in Europe, operates in the Biotechnology, Machine Learning, Pharmaceutical, Health Diagnostics, Precision Medicine sector. The company focuses on Biotechnology and has secured $240.0M in funding across 40 round(s). With a team of 11-50 employees, Allcyte is actively contributing to advancements in Biotechnology. Their latest funding round, Seed Round - Allcyte, raised $6.0M. Discover more about their projects, partnerships, and impact on our platform.